A Bestavashvili Afina, S Glazachev Oleg, A Bestavashvili Alexander, Dhif Ines, Suvorov Alexander Yu, V Vorontsov Nikita, S Tuter Denis, G Gognieva Daria, Yong Zhang, S Pavlov Chavdar, V Glushenkov Dmitriy, A Sirkina Elena, V Kaloshina Irina, Kopylov Philippe Yu
Background: Patients with metabolic syndrome (MS) tend to suffer from comorbidities, and are often simultaneously affected by obesity, dysglycemia, hypertension, and dyslipidemia. This syndrome can be reversed if it is timely diagnosed and treated with a combination of risk factors-reducing lifestyle changes and a tailored pharmacological plan. Interval hypoxic-hyperoxic training (IHHT) has been shown as an effective program in reducing cardiovascular risk factors in patients with MS even in the absence of exercise...
2021: Frontiers in Cardiovascular Medicine